Series B - HALO Diagnostics

Series B - HALO Diagnostics

Investment Firm

Overview

At HALO Diagnostics, our focus is saving lives through early detection with precision diagnostics, preventing and conquering diseases.

Announced Date

Mar 04, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorJames Pallotta
Participant InvestorWarren Jenson
Participant InvestorToba Capital
Participant InvestorRonnie Lott
Participant InvestorAnne Wojcicki

Round Details and Background

HALO Diagnostics raised $19000000 on 2021-03-04 in Series B

At HALO Diagnostics, our focus is saving lives through early detection with precision diagnostics, preventing and conquering diseases.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 04, 2021
Series B - HALO Diagnostics
11-19.0M

Recent Activity

There is no recent news or activity for this profile.